Governance Avacta Group Plc

AVCT

GB00BYYW9G87

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 09:05:21 12/06/2026 pm IST			5-day change	1st Jan Change
71.00 ^GBX	+3.65%		-0.70%	+22.41%

05/06	Avacta Group raises GBP9 million for bond repayments	AN
05/06	Avacta Therapeutics Raises GBP9 Million from Share Issue	MT

Executive Committee: Avacta Group Plc

Manager

Positions heldSince

Christina Coughlin

56 year

Chief Executive Officer

01/04/2024

Brian Hahn

51 year

Director of Finance/CFO	22/01/2025
Corporate Secretary	22/01/2025

David Liebowitz

Chief Tech/Sci/R&D Officer

01/07/2025

Karen Harrison

Chief Operating Officer

Francis X. Wilson

Chief Tech/Sci/R&D Officer

09/02/2026

Composition of the Board of Directors: Avacta Group Plc

Director

CommitteesSince

Shaun Chilton

59 year

Audit Committee	24/06/2024
Compensation Committee	24/06/2024

Paul Fry

60 year

Compensation Committee	03/02/2020
Audit Committee Chair	03/02/2020

Mark Goldberg

71 year

Compensation Committee Chair

01/05/2025

Richard Hughes

58 year

Director/Board Member	28/05/2025
Independent Dir/Board Member	28/05/2025

David Bryant

59 year

Director/Board Member	28/05/2025
Independent Dir/Board Member	28/05/2025

Christina Coughlin

56 year

Director/Board Member

18/03/2022

Latest Appointments: Avacta Group Plc

29/05	Avacta Group plc Announces Board Changes	CI
09/02	Avacta appoints new chief scientific officer, plans clinical trials	AN
09/02	Avacta Therapeutics Names Chemistry Vice President as Chief Scientific Officer	MT
09/02	Avacta Therapeutics Announces Executive Changes	CI
22/25/22	CORRECT (Sep 01): hVIVO appoints Avacta Chair Shaun Chilton to board	AN
01/25/01	HVIVO appoints Avacta Chair Shaun Chilton to lead board	AN
02/25/02	EXECUTIVE CHANGES: Avacta names CMO, Mission Group appoints CEO	AN

More news

Former Officers and Directors: Avacta Group Plc

Insider

Positions held

SinceUntil

Michelle Morrow

Chief Tech/Sci/R&D Officer	04/11/2024	09/02/2026
Corporate Officer/Principal	15/10/2024	04/11/2024

Darlene Deptula-Hicks

Director/Board Member

26/06/2024

01/07/2025

Trevor Nicholls

Director/Board Member	11/06/2018	30/04/2025
Chairman	02/08/2013	11/06/2018
Independent Dir/Board Member	02/08/2013	30/04/2025

Tony Gardiner

Director/Board Member	04/01/2016	13/01/2025
Director of Finance/CFO	04/01/2016	13/01/2025

Eliot Forster

Chairman

11/06/2018

20/06/2024

Fiona McLaughlin

Chief Tech/Sci/R&D Officer	-	01/06/2024
Corporate Officer/Principal	02/09/2021	-

Alastair Smith

Director/Board Member	01/01/2005	01/05/2024
Chief Executive Officer	01/01/2005	01/05/2024
Founder	01/01/2004	01/05/2024

Simon Bennett

Corporate Officer/Principal

19/12/2023

Neil Bell

Corporate Officer/Principal

01/07/2020

01/12/2023

Joanne Soundy

Sales & Marketing

01/11/2020

01/08/2022

Rob Ford

Corporate Officer/Principal

01/08/2020

01/04/2022

Chris Miller

Corporate Officer/Principal

01/12/2017

01/04/2022

Fran Mullen

Corporate Officer/Principal

01/08/2017

01/11/2021

Michael Owen

Director/Board Member	17/09/2015	24/03/2021
Independent Dir/Board Member	-	24/03/2021

Samuel Cameron Williams

Director/Board Member

28/01/2019

04/11/2019

Alan Aubrey

Director/Board Member

13/07/2006

21/01/2019

Jose Saro

Chief Tech/Sci/R&D Officer

12/12/2018

Michael Albin

Director/Board Member

05/02/2014

30/03/2018

Philippe Cotrel

Corporate Officer/Principal

25/01/2016

Timothy Sykes

Director/Board Member	24/12/2010	10/12/2015
Director of Finance/CFO	01/04/2006	10/12/2015
Corporate Secretary	08/02/2010	10/12/2015

Amrik Basran

Chief Tech/Sci/R&D Officer

01/03/2015

Gwynfor Humphreys

Director/Board Member	13/07/2006	23/01/2015
Chairman	24/12/2010	24/01/2014

Anthony William Robards

Director/Board Member

08/02/2010

24/01/2014

Matt Johnson

Chief Tech/Sci/R&D Officer	16/09/2013	-
Corporate Officer/Principal	01/05/2014	-

Richard Craig Alan Slater

Director/Board Member	01/06/2012	20/01/2017
Chief Operating Officer	01/06/2012	-
Director of Finance/CFO	07/07/2015	04/01/2016

Barry Porter

Director/Board Member

08/02/2010

17/03/2011

Daron R. Lee

Director/Board Member

07/08/2006

Russell Winston Hodgetts

Chief Operating Officer

01/10/2005

Kurt Baldwin

Director/Board Member	01/01/2004	24/12/2010
Chief Tech/Sci/R&D Officer	24/12/2010	-
Founder	01/01/2004	-

Simon Webster

Chief Tech/Sci/R&D Officer	08/02/2010	-
Founder	01/01/2004	-

Ged Holmes

Corporate Officer/Principal

Paul Ko Ferrigno

Chief Tech/Sci/R&D Officer

Alexander Stevenson

President

Age distribution of managers

Parity Men Women

Male	10
Female	1

Of which Executive Committee

Male	4
Female	1

Of which Directors

Male	6
Female	0

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Avacta Group plc is a United Kingdom-based life sciences company developing peptide drug conjugates (PDC) targeting anti-tumor payloads directly to the tumor. The Company is focused on the development of its proprietary preCISION technology platform. The preCISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preCISION platform harnesses this tumor-specific protease to cleave preCISION peptide drug conjugates and preCISION antibody/Affimer drug conjugates in the tumor microenvironment, thus releasing active payload in the tumor and reducing systemic exposure and toxicity. Its lead program, AVA6000, is a clinical-stage asset which is a preCISION-enabled form of doxorubicin. AVA6103, the Companyâ€™s second program, is a preCISION-enabled PDC comprised of the preCISION peptide linked to exatecan, the most potent topoisomerase I (topo I) inhibitor in clinical development.

Employees

151

Sector

Biotechnology & Medical Research

More about the company